Find uplifting stories about heroes, innovations, and solutions
45 results for "nhs"
A new cancer injection completely eliminated tumors in 15 patients who had run out of treatment options after their head and neck cancers returned. The five-minute jab also shrank tumors in more than a third of the 102 patients tested, offering new hope for thousands facing similar diagnoses each year.
A groundbreaking gene test can now identify breast cancer patients who can safely skip chemotherapy, sparing two-thirds of people from brutal side effects while maintaining excellent survival rates. Over 5,000 NHS patients annually could avoid the harsh treatment thanks to this breakthrough.
After more than a year of tireless advocacy, a father's campaign has paid off. His 12-year-old son with Duchenne Muscular Dystrophy will finally access a treatment that could help him walk through his entire school career.
Dr. Inna Soldatenko fled Kharkiv with her family when war broke out, arriving in the UK with little more than hope. Three years later, she's practicing medicine again and helping dozens of refugee healthcare workers do the same.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years. The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.
A new one-minute cancer treatment is replacing two-hour hospital sessions for 14,000 patients across England. The breakthrough immunotherapy injection frees patients to live their lives while helping the NHS treat more people faster.
When Theo Kempthorne died suddenly at age eight, his mother's quick decision led to his organs saving four people, including another child and a young father. Now she's encouraging everyone to register as organ donors before tragedy strikes.
Children in the UK will never legally buy cigarettes thanks to a groundbreaking rolling age ban that raises the minimum purchase age by one year, every year. The historic law aims to protect millions from nicotine addiction and save the NHS billions.
A groundbreaking treatment for bile duct cancer has been approved for NHS use, nearly tripling survival time for patients with few other options. The drug gave one young father precious months to meet his newborn son before his death.
Scientists developed an AI tool that identifies advanced bowel cancer patients unlikely to respond to a recently approved NHS drug, potentially sparing thousands from ineffective treatment and serious side effects. The breakthrough could personalize care and guide patients toward therapies that actually work for them.
Two newly approved cancer treatments are giving Scottish patients hope, with one lung cancer drug reducing disease progression by 84%. The drugs offer patients more choices and better outcomes in their fight against cancer.
Nearly 1,000 NHS patients and their families received companionship from volunteers during their final days in a groundbreaking hospital program's first year. The service ensures no one faces their last moments alone.
Patients in England with low-grade brain tumors can now access a groundbreaking pill that slows disease and cuts seizures by 64%. It's the first new brain tumor treatment approved in the UK in two decades.
A new volunteer program helped nearly 1,000 patients and families during end-of-life care in its first year. The "A Friend In Need" service ensures no one faces their final moments alone.
A man who beat childhood leukaemia at age six has returned to healthcare as a children's nurse, inspired by the care he received during three years of treatment. Dan Laird now works at the same hospital trust where he once fought for his life.
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
Patients with low-grade brain tumors in England and Wales can now access vorasidenib, the first new adult brain tumor treatment approved in the UK in two decades. The drug helps patients delay harsh chemotherapy and radiotherapy treatments while living longer without their disease progressing.
England approved its first new brain tumor treatment in 18 years, offering hope to 300 patients living in fear of their tumors growing. For Sally Penny, the pill has already given her a year without side effects and precious time with her children.
Showing 20 of 45